Creegan & Nassoura Financial Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.45M | Hold |
|
|||||
|
2025
Q2 | $1.37M | Hold |
|
|||||
|
2025
Q1 | $1.26M | Sell |
|
|||||
|
2024
Q4 | $1.11M | Sell |
|
|||||
|
2024
Q3 | $1.34M | Sell |
|
|||||
|
2024
Q2 | $1.26M | Sell |
|
|||||
|
2024
Q1 | $1.16M | Hold |
|
|||||
|
2023
Q4 | $1.21M | Hold |
|
|||||
|
2023
Q3 | $1.22M | Hold |
|
|||||
|
2023
Q2 | $1.21M | Sell |
|
|||||
|
2023
Q1 | $1.16M | Hold |
|
|||||
|
2022
Q4 | $1.15M | Sell |
|
|||||
|
2022
Q3 | $1.05M | Hold |
|
|||||
|
2022
Q2 | $1.17M | Sell |
|
|||||
|
2022
Q1 | $1.29M | Sell |
|
|||||
|
2021
Q4 | $1.79M | Hold |
|
|||||
|
2021
Q3 | $1.67M | Sell |
|
|||||
|
2021
Q2 | $1.88M | Sell |
|
|||||
|
2021
Q1 | $1.82M | Sell |
|
|||||
|
2020
Q4 | $2.1M | Hold |
|
|||||
|
2020
Q3 | $1.93M | Hold |
|
|||||
|
2020
Q2 | $1.94M | Sell |
|
|||||
|
2020
Q1 | $1.84M | Hold |
|
|||||
|
2019
Q4 | $2.11M | Buy |
|
|||||
|
2016
Q3 | $2.06M | Sell |
|
|||||
|
2016
Q2 | $2.17M | Sell |
|
|||||
|
2016
Q1 | $1.95M | Sell |
|
|||||
|
2015
Q4 | $2.34M | Sell |
|
|||||
|
2015
Q3 | $2.51M | Sell |
|
|||||
|
2015
Q2 | $2.7M | Hold |
|
|||||
|
2015
Q1 | $2.7M | Sell |
|
|||||
|
2014
Q4 | $2.6M | Buy |
|